Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Male
Vitals: BP 113/73 mmHg, BMI 30.2, Weight 95.2 kg, HR 80 bpm
Labs: Glucose 69.9 mg/dL, Glucose (serum) 69.0 mg/dL, HbA1c 5.1 %, Total Cholesterol 175.3 mg/dL, HDL Cholesterol 65.0 mg/dL, Triglycerides 155.1 mg/dL, Creatinine 2.8 mg/dL
Active conditions: Essential Hypertension
Medications: atorvastatin 40 MG Oral Tablet, lisinopril 20 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)
- Age 48 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Female
Vitals: BP 102/89 mmHg, BMI 20.6, Weight 53.7 kg, HR 64 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 102/89 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 53yo Female
Vitals: BP 137/99 mmHg, BMI 28.4, Weight 75.2 kg, HR 97 bpm
Labs: Glucose 65.0 mg/dL, Glucose (serum) 65.0 mg/dL, HbA1c 2.6 %, Total Cholesterol 219.8 mg/dL, HDL Cholesterol 48.1 mg/dL, Triglycerides 121.6 mg/dL, Creatinine 2.4 mg/dL
Active conditions: Type 2 Diabetes, Diabetic Retinopathy, Diabetic Kidney Disease, Essential Hypertension
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Male
Vitals: BP 118/93 mmHg, BMI 27.7, Weight 96.2 kg, HR 62 bpm
Labs: Glucose 68.2 mg/dL, HbA1c 6.0 %, Total Cholesterol 143.0 mg/dL, HDL Cholesterol 57.3 mg/dL, Triglycerides 133.2 mg/dL, Creatinine 1.1 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 27.7 (overweight)
- Age 61 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 2yo Male
Vitals: BP 140/85 mmHg, BMI 16.7, Weight 14.7 kg, HR 93 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 140/85 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Male
Vitals: BP 125/75 mmHg, BMI 22.7, Weight 79.6 kg, HR 94 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 125/75 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Female
Vitals: BP 133/92 mmHg, BMI 20.0, Weight 52.5 kg, HR 72 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 133/92 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 24yo Male
Vitals: BP 114/73 mmHg, BMI 29.0, Weight 94.9 kg, HR 64 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.0 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 47yo Female
Vitals: BP 111/67 mmHg, BMI 28.0, Weight 75.3 kg, HR 92 bpm
Labs: Total Cholesterol 222.6 mg/dL, HDL Cholesterol 57.7 mg/dL, Triglycerides 149.1 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.0 (overweight)
- Age 47 years (≥45 increases risk)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 40yo Male
Vitals: BP 127/76 mmHg, BMI 28.6, Weight 81.1 kg, HR 89 bpm
Labs: Total Cholesterol 194.1 mg/dL, HDL Cholesterol 55.0 mg/dL, Triglycerides 106.4 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.6 (overweight)

**Hypertension: LOW**
- BP 127/76 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 44yo Female
Vitals: BP 133/80 mmHg, BMI 29.3, Weight 80.7 kg, HR 82 bpm
Labs: Glucose 66.1 mg/dL, HbA1c 6.3 %, Total Cholesterol 182.6 mg/dL, HDL Cholesterol 57.1 mg/dL, Triglycerides 112.2 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 29.3 (overweight)
- History of prediabetes

**Hypertension: MODERATE**
- BP 133/80 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Male
Vitals: BP 111/71 mmHg, BMI 14.8, Weight 24.3 kg, HR 63 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Female
Vitals: BP 115/74 mmHg, BMI 15.6, Weight 25.2 kg, HR 99 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Female
Vitals: BP 118/84 mmHg, BMI 23.1, Weight 60.5 kg, HR 71 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 118/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 10yo Male
Vitals: BP 134/72 mmHg, BMI 16.4, Weight 28.0 kg, HR 94 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 134/72 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 37yo Female
Vitals: BP 114/88 mmHg, BMI 28.6, Weight 75.7 kg, HR 75 bpm
Labs: Glucose 68.8 mg/dL, HbA1c 6.3 %, Total Cholesterol 190.9 mg/dL, HDL Cholesterol 60.8 mg/dL, Triglycerides 111.8 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.6 (overweight)
- History of prediabetes

**Hypertension: MODERATE**
- BP 114/88 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 60yo Female
Vitals: BP 118/77 mmHg, BMI 28.4, Weight 67.2 kg, HR 84 bpm
Labs: Glucose 70.3 mg/dL, HbA1c 6.0 %, Total Cholesterol 198.4 mg/dL, HDL Cholesterol 58.8 mg/dL, Triglycerides 129.9 mg/dL, Creatinine 0.6 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 28.4 (overweight)
- Age 60 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 60 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Male
Vitals: BP 123/68 mmHg, BMI 29.4, Weight 87.0 kg, HR 87 bpm
Labs: Glucose 98.7 mg/dL, Glucose (serum) 74.1 mg/dL, HbA1c 6.2 %, Total Cholesterol 163.2 mg/dL, HDL Cholesterol 50.7 mg/dL, Triglycerides 125.2 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 29.4 (overweight)
- Age 66 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 28yo Female
Vitals: BP 91/69 mmHg, BMI 27.3, Weight 73.5 kg, HR 78 bpm
Labs: Glucose 69.0 mg/dL, HbA1c 6.3 %, Creatinine 1.0 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 27.3 (overweight)
- History of prediabetes

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Male
Vitals: BP 140/80 mmHg, BMI 30.3, Weight 90.8 kg, HR 72 bpm
Labs: Glucose 93.9 mg/dL, HbA1c 6.3 %, Total Cholesterol 179.2 mg/dL, HDL Cholesterol 56.1 mg/dL, Triglycerides 117.6 mg/dL, Creatinine 1.4 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 30.3 (obese)
- Age 49 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 140/80 mmHg (Stage 1+ hypertension)
- BMI 30.3 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 25yo Male
Vitals: BP 121/77 mmHg, BMI 27.2, Weight 85.2 kg, HR 85 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.2 (overweight)

**Hypertension: LOW**
- BP 121/77 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 72yo Male
Vitals: BP 92/60 mmHg, BMI 30.1, Weight 98.0 kg, HR 87 bpm
Labs: Glucose 88.1 mg/dL, HbA1c 6.0 %, Total Cholesterol 184.2 mg/dL, HDL Cholesterol 45.3 mg/dL, Triglycerides 198.2 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 30.1 (obese)
- Age 72 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 99yo Female
Vitals: BP 105/62 mmHg, BMI 27.8, Weight 74.8 kg, HR 65 bpm
Labs: Glucose 65.5 mg/dL, HbA1c 6.2 %, Total Cholesterol 171.6 mg/dL, HDL Cholesterol 33.7 mg/dL, Triglycerides 121.1 mg/dL, Creatinine 0.4 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 27.8 (overweight)
- Age 99 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 99 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 113/63 mmHg, BMI 17.5, Weight 41.8 kg, HR 60 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 82yo Male
Vitals: BP 106/72 mmHg, BMI 27.8, Weight 95.6 kg, HR 61 bpm
Labs: Glucose (serum) 95.1 mg/dL, HbA1c 5.5 %, Total Cholesterol 152.1 mg/dL, HDL Cholesterol 56.7 mg/dL, Triglycerides 106.6 mg/dL
Active conditions: Essential Hypertension, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.8 (overweight)
- Age 82 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 54yo Female
Vitals: BP 116/84 mmHg, BMI 30.6, Weight 84.1 kg, HR 74 bpm
Labs: Glucose 87.4 mg/dL, Total Cholesterol 196.7 mg/dL, HDL Cholesterol 61.5 mg/dL, Triglycerides 122.0 mg/dL, Creatinine 2.9 mg/dL
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.6 (obese)
- Age 54 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 116/84 mmHg (elevated)
- BMI 30.6 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 30yo Male
Vitals: BP 124/81 mmHg, BMI 25.5, Weight 79.0 kg, HR 67 bpm
Active conditions: Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 25.5 (overweight)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 54yo Female
Vitals: BP 96/84 mmHg, BMI 30.0, Weight 70.5 kg, HR 96 bpm
Labs: Glucose 74.0 mg/dL, Total Cholesterol 196.8 mg/dL, HDL Cholesterol 56.5 mg/dL, Triglycerides 164.1 mg/dL, Creatinine 2.8 mg/dL
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.0 (obese)
- Age 54 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 96/84 mmHg (elevated)
- BMI 30.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 73yo Male
Vitals: BP 125/74 mmHg, BMI 27.5, Weight 73.3 kg, HR 95 bpm
Labs: Glucose 86.4 mg/dL, Glucose (serum) 86.4 mg/dL, HbA1c 3.1 %, Total Cholesterol 193.6 mg/dL, HDL Cholesterol 46.1 mg/dL, Triglycerides 142.1 mg/dL, Creatinine 2.1 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Diabetic Kidney Disease
Medications: simvastatin 20 MG Oral Tablet, Simvastatin 10 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 27.5 (overweight)
- Age 73 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 64yo Male
Vitals: BP 121/82 mmHg, BMI 30.1, Weight 98.4 kg, HR 78 bpm
Labs: Glucose 90.6 mg/dL, Glucose (serum) 85.7 mg/dL, HbA1c 6.1 %, Total Cholesterol 223.4 mg/dL, HDL Cholesterol 50.4 mg/dL, Triglycerides 106.0 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 30.1 (obese)
- Age 64 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 121/82 mmHg (elevated)
- BMI 30.1 (obesity increases BP risk)
- Age 64 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 62yo Male
Vitals: BP 130/97 mmHg, BMI 30.1, Weight 86.5 kg, HR 90 bpm
Labs: Glucose 82.9 mg/dL, Glucose (serum) 82.9 mg/dL, HbA1c 3.0 %, Total Cholesterol 168.1 mg/dL, HDL Cholesterol 63.5 mg/dL, Triglycerides 142.3 mg/dL, Creatinine 1.6 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 62 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Female
Vitals: BP 105/85 mmHg, BMI 22.8, Weight 62.2 kg, HR 90 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 105/85 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 55yo Female
Vitals: BP 108/75 mmHg, BMI 28.8, Weight 69.8 kg, HR 73 bpm
Labs: Glucose 83.8 mg/dL, HbA1c 6.4 %, Total Cholesterol 153.8 mg/dL, HDL Cholesterol 25.1 mg/dL, Triglycerides 104.4 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.4% (prediabetes range 5.7-6.4%)
- BMI 28.8 (overweight)
- Age 55 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 55 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 16yo Female
Vitals: BP 91/71 mmHg, BMI 16.4, Weight 47.8 kg, HR 92 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Female
Vitals: BP 126/85 mmHg, BMI 30.1, Weight 77.9 kg, HR 97 bpm
Labs: Glucose 72.8 mg/dL, HbA1c 6.2 %, Total Cholesterol 163.0 mg/dL, HDL Cholesterol 57.2 mg/dL, Triglycerides 111.8 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 30.1 (obese)
- Age 49 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Female
Vitals: BP 138/107 mmHg, BMI 30.5, Weight 78.7 kg, HR 85 bpm
Labs: Glucose 84.2 mg/dL, Glucose (serum) 84.2 mg/dL, HbA1c 3.1 %, Total Cholesterol 193.0 mg/dL, HDL Cholesterol 58.5 mg/dL, Triglycerides 128.9 mg/dL, Creatinine 1.4 mg/dL
Active conditions: Type 2 Diabetes, Diabetic Neuropathy, Essential Hypertension, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 55yo Female
Vitals: BP 113/88 mmHg, BMI 27.4, Weight 67.0 kg, HR 99 bpm
Labs: Total Cholesterol 178.9 mg/dL, HDL Cholesterol 47.1 mg/dL, Triglycerides 123.2 mg/dL
Active conditions: Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.4 (overweight)
- Age 55 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 44yo Male
Vitals: BP 122/75 mmHg, BMI 24.7, Weight 81.4 kg, HR 70 bpm
Labs: Glucose (serum) 90.2 mg/dL, HbA1c 5.5 %, Total Cholesterol 191.1 mg/dL, HDL Cholesterol 34.1 mg/dL, Triglycerides 132.7 mg/dL
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 122/75 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 60yo Female
Vitals: BP 133/90 mmHg, BMI 27.9, Weight 76.4 kg, HR 60 bpm
Labs: Glucose 64.4 mg/dL, HbA1c 6.3 %, Total Cholesterol 156.7 mg/dL, HDL Cholesterol 44.8 mg/dL, Triglycerides 148.5 mg/dL, Creatinine 2.6 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 27.9 (overweight)
- Age 60 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 133/90 mmHg (Stage 1+ hypertension)
- Age 60 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 3yo Female
Vitals: BP 101/69 mmHg, BMI 15.1, Weight 12.7 kg, HR 77 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 1yo Male
Vitals: BP 124/72 mmHg, Weight 12.7 kg, HR 97 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 124/72 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 21yo Male
Vitals: BP 128/73 mmHg, BMI 23.1, Weight 87.5 kg, HR 72 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 128/73 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 24yo Female
Vitals: BP 126/73 mmHg, BMI 22.9, Weight 59.6 kg, HR 76 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 126/73 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Male
Vitals: BP 102/81 mmHg, BMI 36.2, Weight 131.1 kg, HR 92 bpm
Labs: Glucose (serum) 76.1 mg/dL, Total Cholesterol 187.4 mg/dL, HDL Cholesterol 51.5 mg/dL, Triglycerides 144.3 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 36.2 (obese)
- Age 49 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 102/81 mmHg (elevated)
- BMI 36.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 43yo Male
Vitals: BP 133/89 mmHg, BMI 33.8, Weight 114.4 kg, HR 73 bpm
Labs: Glucose 89.7 mg/dL, HbA1c 6.3 %, Total Cholesterol 237.7 mg/dL, HDL Cholesterol 48.9 mg/dL, Triglycerides 109.0 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 33.8 (obese)
- History of prediabetes

**Hypertension: MODERATE**
- BP 133/89 mmHg (elevated)
- BMI 33.8 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 23yo Male
Vitals: BP 117/72 mmHg, BMI 22.2, Weight 68.5 kg, HR 75 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 42yo Female
Vitals: BP 115/69 mmHg, BMI 29.4, Weight 70.7 kg, HR 89 bpm
Labs: Total Cholesterol 271.9 mg/dL, HDL Cholesterol 59.8 mg/dL, Triglycerides 131.3 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.4 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 29yo Female
Vitals: BP 133/76 mmHg, BMI 27.5, Weight 66.3 kg, HR 76 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.5 (overweight)

**Hypertension: MODERATE**
- BP 133/76 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 50yo Female
Vitals: BP 130/79 mmHg, BMI 28.3, Weight 72.1 kg, HR 65 bpm
Labs: Total Cholesterol 270.9 mg/dL, HDL Cholesterol 58.9 mg/dL, Triglycerides 142.1 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.3 (overweight)
- Age 50 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 130/79 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 78yo Female
Vitals: BP 140/86 mmHg, BMI 27.3, Weight 74.2 kg, HR 71 bpm
Labs: Total Cholesterol 264.5 mg/dL, HDL Cholesterol 44.9 mg/dL, Triglycerides 105.9 mg/dL
Active conditions: Essential Hypertension
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.3 (overweight)
- Age 78 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 43yo Female
Vitals: BP 140/88 mmHg, BMI 30.5, Weight 72.8 kg, HR 67 bpm
Labs: Glucose 88.7 mg/dL, HbA1c 5.8 %, Total Cholesterol 315.1 mg/dL, HDL Cholesterol 54.3 mg/dL, Triglycerides 146.8 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 30.5 (obese)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Male
Vitals: BP 117/77 mmHg, BMI 30.1, Weight 90.1 kg, HR 80 bpm
Labs: Total Cholesterol 139.0 mg/dL, HDL Cholesterol 50.4 mg/dL, Triglycerides 117.4 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 48 years (≥45 increases risk)

**Hypertension: MODERATE**
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Male
Vitals: BP 119/69 mmHg, BMI 28.2, Weight 95.9 kg, HR 84 bpm
Labs: Glucose 70.5 mg/dL, HbA1c 6.3 %, Total Cholesterol 106.8 mg/dL, HDL Cholesterol 57.8 mg/dL, Triglycerides 138.1 mg/dL, Creatinine 1.2 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.2 (overweight)
- Age 48 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 49yo Female
Vitals: BP 120/67 mmHg, BMI 30.2, Weight 77.8 kg, HR 91 bpm
Labs: Glucose 90.1 mg/dL, HbA1c 6.3 %, Total Cholesterol 291.0 mg/dL, HDL Cholesterol 55.2 mg/dL, Triglycerides 104.2 mg/dL, Creatinine 1.2 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 30.2 (obese)
- Age 49 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 120/67 mmHg (slightly elevated)
- BMI 30.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 95/65 mmHg, BMI 18.5, Weight 50.3 kg, HR 67 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 28yo Female
Vitals: BP 100/71 mmHg, BMI 24.0, Weight 60.3 kg, HR 90 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 47yo Male
Vitals: BP 119/86 mmHg, BMI 30.1, Weight 96.9 kg, HR 99 bpm
Labs: Total Cholesterol 180.8 mg/dL, HDL Cholesterol 54.6 mg/dL, Triglycerides 143.7 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)
- Age 47 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 119/86 mmHg (elevated)
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 38yo Male
Vitals: BP 137/102 mmHg, BMI 30.3, Weight 102.4 kg, HR 94 bpm
Labs: Total Cholesterol 128.7 mg/dL, HDL Cholesterol 55.7 mg/dL, Triglycerides 113.4 mg/dL
Active conditions: Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.3 (obese)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 63yo Female
Vitals: BP 136/108 mmHg, BMI 35.9, Weight 104.7 kg, HR 66 bpm
Labs: Glucose 90.7 mg/dL, Glucose (serum) 80.5 mg/dL, HbA1c 5.7 %, Total Cholesterol 178.3 mg/dL, HDL Cholesterol 60.7 mg/dL, Triglycerides 136.9 mg/dL, Creatinine 2.5 mg/dL
Active conditions: Essential Hypertension, Diabetic Kidney Disease
Medications: amLODIPine 2.5 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.7% (prediabetes range 5.7-6.4%)
- BMI 35.9 (obese)
- Age 63 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 95/74 mmHg, BMI 23.5, Weight 55.1 kg, HR 60 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 58yo Male
Vitals: BP 79/60 mmHg, BMI 28.0, Weight 89.3 kg, HR 80 bpm
Labs: Glucose 79.5 mg/dL, HbA1c 6.3 %, Total Cholesterol 160.2 mg/dL, HDL Cholesterol 46.1 mg/dL, Triglycerides 106.9 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.0 (overweight)
- Age 58 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 58 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 58yo Male
Vitals: BP 110/68 mmHg, BMI 27.3, Weight 77.1 kg, HR 76 bpm
Labs: Glucose 111.2 mg/dL, Glucose (serum) 86.1 mg/dL, HbA1c 6.8 %, Total Cholesterol 203.2 mg/dL, HDL Cholesterol 48.3 mg/dL, Triglycerides 160.4 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Diabetic Neuropathy
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: LOW**
- Age 58 years (≥55 increases risk)

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 56yo Male
Vitals: BP 137/88 mmHg, BMI 28.6, Weight 82.3 kg, HR 61 bpm
Labs: Glucose 90.7 mg/dL, HbA1c 6.3 %, Total Cholesterol 288.0 mg/dL, HDL Cholesterol 33.5 mg/dL, Triglycerides 120.7 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.6 (overweight)
- Age 56 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Male
Vitals: BP 113/79 mmHg, BMI 15.1, Weight 22.5 kg, HR 62 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 27yo Female
Vitals: BP 143/108 mmHg, BMI 27.7, Weight 76.9 kg, HR 87 bpm
Active conditions: Essential Hypertension
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.7 (overweight)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Male
Vitals: BP 106/84 mmHg, BMI 24.9, Weight 75.7 kg, HR 75 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 106/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 86/53 mmHg, BMI 27.8, Weight 66.0 kg, HR 65 bpm
Labs: Glucose 97.8 mg/dL, HbA1c 5.9 %, Total Cholesterol 194.3 mg/dL, HDL Cholesterol 52.6 mg/dL, Triglycerides 148.1 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 27.8 (overweight)
- Age 61 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 60yo Female
Vitals: BP 111/92 mmHg, BMI 28.0, Weight 73.9 kg, HR 64 bpm
Labs: Total Cholesterol 193.8 mg/dL, HDL Cholesterol 55.3 mg/dL, Triglycerides 110.7 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.0 (overweight)
- Age 60 years (≥45 increases risk)

**Hypertension: HIGH**
- BP 111/92 mmHg (Stage 1+ hypertension)
- Age 60 years (≥55 increases risk)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 80yo Male
Vitals: BP 108/75 mmHg, BMI 27.7, Weight 84.7 kg, HR 97 bpm
Labs: Glucose 114.8 mg/dL, Glucose (serum) 114.8 mg/dL, HbA1c 3.9 %, Total Cholesterol 203.2 mg/dL, HDL Cholesterol 46.7 mg/dL, Triglycerides 191.6 mg/dL, Creatinine 4.4 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Type 2 Diabetes, Diabetic Neuropathy, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, simvastatin 40 MG Oral Tablet, lisinopril 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], Hydrochlorothiazide 25 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Female
Vitals: BP 116/76 mmHg, BMI 18.2, Weight 47.5 kg, HR 96 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Male
Vitals: BP 128/82 mmHg, BMI 25.9, Weight 66.2 kg, HR 73 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 25.9 (overweight)

**Hypertension: MODERATE**
- BP 128/82 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 27yo Male
Vitals: BP 105/81 mmHg, BMI 24.5, Weight 70.9 kg, HR 85 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 105/81 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 41yo Male
Vitals: BP 143/92 mmHg, BMI 27.4, Weight 90.4 kg, HR 77 bpm
Labs: Glucose 93.0 mg/dL, HbA1c 6.0 %, Total Cholesterol 105.6 mg/dL, HDL Cholesterol 59.5 mg/dL, Triglycerides 132.5 mg/dL, Creatinine 1.6 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 27.4 (overweight)
- History of prediabetes

**Hypertension: HIGH**
- BP 143/92 mmHg (Stage 1+ hypertension)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 11yo Female
Vitals: BP 132/79 mmHg, BMI 19.2, Weight 44.0 kg, HR 65 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 132/79 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 83yo Female
Vitals: BP 95/80 mmHg, BMI 28.4, Weight 82.0 kg, HR 68 bpm
Labs: Glucose 82.9 mg/dL, HbA1c 5.8 %, Total Cholesterol 150.6 mg/dL, HDL Cholesterol 43.0 mg/dL, Triglycerides 139.7 mg/dL, Creatinine 0.6 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 28.4 (overweight)
- Age 83 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 4yo Male
Vitals: BP 96/70 mmHg, BMI 15.6, Weight 20.8 kg, HR 86 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Male
Vitals: BP 103/62 mmHg, BMI 30.1, Weight 96.1 kg, HR 74 bpm
Labs: Glucose 72.1 mg/dL, Glucose (serum) 94.0 mg/dL, HbA1c 6.2 %, Total Cholesterol 170.9 mg/dL, HDL Cholesterol 47.7 mg/dL, Triglycerides 148.9 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.2% (prediabetes range 5.7-6.4%)
- BMI 30.1 (obese)
- Age 66 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BMI 30.1 (obesity increases BP risk)
- Age 66 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 10yo Male
Vitals: BP 81/79 mmHg, BMI 16.0, Weight 31.6 kg, HR 66 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 18yo Female
Vitals: BP 122/82 mmHg, BMI 18.9, Weight 50.3 kg, HR 62 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 122/82 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 8yo Female
Vitals: BP 138/78 mmHg, BMI 13.9, Weight 20.1 kg, HR 63 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 138/78 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 60yo Female
Vitals: BP 133/71 mmHg, BMI 28.4, Weight 68.1 kg, HR 78 bpm
Labs: Glucose 73.6 mg/dL, HbA1c 5.9 %, Total Cholesterol 196.1 mg/dL, HDL Cholesterol 67.3 mg/dL, Triglycerides 166.9 mg/dL, Creatinine 3.5 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 28.4 (overweight)
- Age 60 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BP 133/71 mmHg (elevated)
- Age 60 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 2yo Male
Vitals: BP 138/87 mmHg, BMI 17.1, Weight 17.0 kg, HR 84 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 138/87 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 128/77 mmHg, BMI 27.5, Weight 64.5 kg, HR 85 bpm
Labs: Glucose 85.2 mg/dL, Glucose (serum) 88.4 mg/dL, HbA1c 3.2 %, Total Cholesterol 196.5 mg/dL, HDL Cholesterol 46.8 mg/dL, Triglycerides 105.6 mg/dL, Creatinine 2.8 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 27.5 (overweight)
- Age 61 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Female
Vitals: BP 115/92 mmHg, BMI 14.9, Weight 21.2 kg, HR 74 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 115/92 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 73yo Male
Vitals: BP 130/73 mmHg, BMI 30.3, Weight 102.0 kg, HR 69 bpm
Labs: Glucose 86.5 mg/dL, Glucose (serum) 97.9 mg/dL, HbA1c 6.3 %, Total Cholesterol 173.0 mg/dL, HDL Cholesterol 51.1 mg/dL, Triglycerides 144.5 mg/dL, Creatinine 1.0 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 30.3 (obese)
- Age 73 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 34yo Male
Vitals: BP 124/71 mmHg, BMI 26.5, Weight 87.4 kg, HR 95 bpm
Labs: Glucose 71.4 mg/dL, HbA1c 6.1 %, Total Cholesterol 214.0 mg/dL, HDL Cholesterol 58.4 mg/dL, Triglycerides 112.2 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 26.5 (overweight)
- History of prediabetes

**Hypertension: LOW**
- BP 124/71 mmHg (slightly elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 46yo Female
Vitals: BP 113/71 mmHg, BMI 29.0, Weight 77.6 kg, HR 67 bpm
Labs: Glucose 68.0 mg/dL, HbA1c 6.1 %, Total Cholesterol 158.2 mg/dL, HDL Cholesterol 27.7 mg/dL, Triglycerides 119.7 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 29.0 (overweight)
- Age 46 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Male
Vitals: BP 106/80 mmHg, BMI 28.9, Weight 85.3 kg, HR 96 bpm
Labs: Glucose 69.3 mg/dL, HbA1c 6.3 %, Creatinine 1.4 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.9 (overweight)
- History of prediabetes

**Hypertension: MODERATE**
- BP 106/80 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 42yo Female
Vitals: BP 112/69 mmHg, BMI 27.9, Weight 69.5 kg, HR 84 bpm
Labs: Total Cholesterol 191.1 mg/dL, HDL Cholesterol 53.5 mg/dL, Triglycerides 112.8 mg/dL
Active conditions: Essential Hypertension
Medications: lisinopril 10 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.9 (overweight)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 17yo Female
Vitals: BP 131/87 mmHg, BMI 22.4, Weight 67.6 kg, HR 85 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 131/87 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 58yo Male
Vitals: BP 131/95 mmHg, BMI 30.3, Weight 80.9 kg, HR 76 bpm
Labs: Glucose 91.3 mg/dL, HbA1c 7.6 %, Total Cholesterol 183.0 mg/dL, HDL Cholesterol 53.4 mg/dL, Triglycerides 109.1 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Type 2 Diabetes
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 2yo Female
Vitals: BP 115/70 mmHg, BMI 15.2, Weight 12.9 kg, HR 79 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 16yo Female
Vitals: BP 104/84 mmHg, BMI 19.0, Weight 55.6 kg, HR 66 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 104/84 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 32yo Female
Vitals: BP 135/80 mmHg, BMI 28.4, Weight 74.1 kg, HR 93 bpm
Labs: Total Cholesterol 269.4 mg/dL, HDL Cholesterol 47.8 mg/dL, Triglycerides 106.5 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 28.4 (overweight)

**Hypertension: MODERATE**
- BP 135/80 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 29yo Female
Vitals: BP 93/82 mmHg, BMI 29.7, Weight 76.0 kg, HR 69 bpm
Labs: Glucose 64.8 mg/dL, HbA1c 6.1 %, Creatinine 1.6 mg/dL
Active conditions: Essential Hypertension, Prediabetes
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.1% (prediabetes range 5.7-6.4%)
- BMI 29.7 (overweight)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 14yo Male
Vitals: BP 119/83 mmHg, BMI 23.7, Weight 73.6 kg, HR 93 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 119/83 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 51yo Male
Vitals: BP 135/69 mmHg, BMI 30.0, Weight 90.2 kg, HR 66 bpm
Labs: Glucose 89.9 mg/dL, HbA1c 6.0 %, Total Cholesterol 172.7 mg/dL, HDL Cholesterol 53.4 mg/dL, Triglycerides 126.4 mg/dL, Creatinine 3.3 mg/dL
Active conditions: Prediabetes, Type 2 Diabetes, Diabetic Retinopathy
Medications: 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: MODERATE**
- BP 135/69 mmHg (elevated)
- BMI 30.0 (obesity increases BP risk)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 41yo Male
Vitals: BP 150/91 mmHg, BMI 30.1, Weight 95.6 kg, HR 100 bpm
Labs: Total Cholesterol 163.4 mg/dL, HDL Cholesterol 27.5 mg/dL, Triglycerides 121.7 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.1 (obese)

**Hypertension: HIGH**
- BP 150/91 mmHg (Stage 1+ hypertension)
- BMI 30.1 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 48yo Male
Vitals: BP 145/81 mmHg, BMI 28.3, Weight 89.3 kg, HR 85 bpm
Labs: Glucose 86.1 mg/dL, HbA1c 6.3 %, Total Cholesterol 218.2 mg/dL, HDL Cholesterol 25.4 mg/dL, Triglycerides 302.8 mg/dL, Creatinine 1.1 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 10 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 28.3 (overweight)
- Age 48 years (≥45 increases risk)
- History of prediabetes

**Hypertension: HIGH**
- BP 145/81 mmHg (Stage 1+ hypertension)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 24yo Female
Vitals: BP 113/76 mmHg, BMI 30.3, Weight 83.4 kg, HR 70 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.3 (obese)

**Hypertension: MODERATE**
- BMI 30.3 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Male
Vitals: BP 108/73 mmHg, BMI 28.2, Weight 81.2 kg, HR 98 bpm
Labs: Glucose 93.4 mg/dL, Glucose (serum) 64.6 mg/dL, HbA1c 5.8 %, Total Cholesterol 271.8 mg/dL, HDL Cholesterol 50.9 mg/dL, Triglycerides 126.5 mg/dL, Creatinine 0.8 mg/dL
Active conditions: Prediabetes
Medications: Simvastatin 20 MG Oral Tablet, bisoprolol fumarate 2.5 MG / hydrochlorothiazide 6.25 MG Oral Tablet, lisinopril 20 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.8% (prediabetes range 5.7-6.4%)
- BMI 28.2 (overweight)
- Age 66 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- Age 66 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 42yo Female
Vitals: BP 113/64 mmHg, BMI 30.2, Weight 81.2 kg, HR 92 bpm
Labs: Total Cholesterol 323.1 mg/dL, HDL Cholesterol 63.5 mg/dL, Triglycerides 147.2 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.2 (obese)

**Hypertension: MODERATE**
- BMI 30.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 51yo Female
Vitals: BP 93/81 mmHg, BMI 27.2, Weight 81.2 kg, HR 91 bpm
Labs: Total Cholesterol 249.7 mg/dL, HDL Cholesterol 62.9 mg/dL, Triglycerides 127.2 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.2 (overweight)
- Age 51 years (≥45 increases risk)

**Hypertension: MODERATE**
- BP 93/81 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 5yo Female
Vitals: BP 145/73 mmHg, BMI 16.8, Weight 19.1 kg, HR 68 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 145/73 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 61yo Female
Vitals: BP 138/90 mmHg, BMI 30.0, Weight 69.4 kg, HR 99 bpm
Labs: Total Cholesterol 152.5 mg/dL, HDL Cholesterol 57.1 mg/dL, Triglycerides 118.5 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 30.0 (obese)
- Age 61 years (≥45 increases risk)

**Hypertension: HIGH**
- BP 138/90 mmHg (Stage 1+ hypertension)
- BMI 30.0 (obesity increases BP risk)
- Age 61 years (≥55 increases risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Confirm elevated BP on 2 separate occasions
4. Consider initiating antihypertensive therapy
5. Order baseline labs: renal function, electrolytes, lipid panel
6. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 22yo Female
Vitals: BP 99/73 mmHg, BMI 23.8, Weight 62.4 kg, HR 86 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 41yo Female
Vitals: BP 103/79 mmHg, BMI 29.5, Weight 77.0 kg, HR 80 bpm
Labs: Total Cholesterol 161.7 mg/dL, HDL Cholesterol 61.2 mg/dL, Triglycerides 143.4 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.5 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 40yo Female
Vitals: BP 141/77 mmHg, BMI 28.8, Weight 85.5 kg, HR 90 bpm
Labs: Glucose 72.1 mg/dL, HbA1c 6.4 %, Total Cholesterol 204.1 mg/dL, HDL Cholesterol 52.8 mg/dL, Triglycerides 128.7 mg/dL, Creatinine 1.1 mg/dL
Active conditions: Prediabetes, Essential Hypertension
Medications: amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.4% (prediabetes range 5.7-6.4%)
- BMI 28.8 (overweight)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 9yo Male
Vitals: BP 121/67 mmHg, BMI 20.6, Weight 36.6 kg, HR 97 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- BP 121/67 mmHg (slightly elevated)

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 42yo Male
Vitals: BP 104/63 mmHg, BMI 29.4, Weight 86.3 kg, HR 90 bpm
Labs: Total Cholesterol 317.2 mg/dL, HDL Cholesterol 63.1 mg/dL, Triglycerides 148.5 mg/dL
Active conditions: Essential Hypertension
Medications: Hydrochlorothiazide 25 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.4 (overweight)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 52yo Male
Vitals: BP 133/87 mmHg, BMI 29.7, Weight 84.6 kg, HR 60 bpm
Labs: Glucose 77.4 mg/dL, Glucose (serum) 77.4 mg/dL, HbA1c 3.1 %, Total Cholesterol 172.3 mg/dL, HDL Cholesterol 56.3 mg/dL, Triglycerides 121.7 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Essential Hypertension, Prediabetes, Diabetic Kidney Disease
Medications: Simvastatin 10 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], losartan potassium 25 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 29.7 (overweight)
- Age 52 years (≥45 increases risk)
- History of prediabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 26yo Male
Vitals: BP 103/80 mmHg, BMI 28.2, Weight 92.5 kg, HR 86 bpm
Labs: Glucose 77.6 mg/dL, HbA1c 5.9 %, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 5.9% (prediabetes range 5.7-6.4%)
- BMI 28.2 (overweight)
- History of prediabetes

**Hypertension: MODERATE**
- BP 103/80 mmHg (elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 6yo Male
Vitals: BP 141/73 mmHg, BMI 15.6, Weight 19.2 kg, HR 69 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: HIGH**
- BP 141/73 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 72yo Male
Vitals: BP 115/83 mmHg, BMI 27.8, Weight 84.3 kg, HR 81 bpm
Labs: Glucose (serum) 95.0 mg/dL, HbA1c 5.6 %, Total Cholesterol 148.4 mg/dL, HDL Cholesterol 54.6 mg/dL, Triglycerides 100.9 mg/dL
Active conditions: Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, lisinopril 10 MG Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 27.8 (overweight)
- Age 72 years (≥45 increases risk)

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 27yo Female
Vitals: BP 120/91 mmHg, BMI 29.0, Weight 87.2 kg, HR 72 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.0 (overweight)

**Hypertension: HIGH**
- BP 120/91 mmHg (Stage 1+ hypertension)

## Recommendations
1. Confirm elevated BP on 2 separate occasions
2. Consider initiating antihypertensive therapy
3. Order baseline labs: renal function, electrolytes, lipid panel
4. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 32yo Female
Vitals: BP 104/79 mmHg, BMI 29.2, Weight 74.8 kg, HR 100 bpm
Labs: Total Cholesterol 164.5 mg/dL, HDL Cholesterol 51.1 mg/dL, Triglycerides 136.0 mg/dL

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- BMI 29.2 (overweight)

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 14yo Male
Vitals: BP 99/78 mmHg, BMI 23.3, Weight 64.8 kg, HR 72 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: LOW**
- No significant risk factors identified

## Recommendations
1. Continue healthy lifestyle habits
2. Annual wellness visit and screening


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 24yo Female
Vitals: BP 110/82 mmHg, BMI 31.3, Weight 84.2 kg, HR 97 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- BMI 31.3 (obese)

**Hypertension: MODERATE**
- BP 110/82 mmHg (elevated)
- BMI 31.3 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 36yo Male
Vitals: BP 99/88 mmHg, BMI 30.2, Weight 102.3 kg, HR 81 bpm
Labs: Glucose 85.1 mg/dL, HbA1c 6.0 %, Total Cholesterol 302.2 mg/dL, HDL Cholesterol 28.3 mg/dL, Triglycerides 132.9 mg/dL, Creatinine 1.5 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- BMI 30.2 (obese)
- History of prediabetes

**Hypertension: MODERATE**
- BP 99/88 mmHg (elevated)
- BMI 30.2 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 46yo Female
Vitals: BP 126/70 mmHg, BMI 21.0, Weight 56.9 kg, HR 84 bpm
Labs: Glucose 91.7 mg/dL, HbA1c 6.0 %, Total Cholesterol 306.4 mg/dL, HDL Cholesterol 56.5 mg/dL, Triglycerides 127.9 mg/dL, Creatinine 0.6 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.0% (prediabetes range 5.7-6.4%)
- Age 46 years (≥45 increases risk)
- History of prediabetes

**Hypertension: LOW**
- BP 126/70 mmHg (slightly elevated)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 52yo Male
Vitals: BP 127/71 mmHg, BMI 30.0, Weight 95.1 kg, HR 87 bpm
Labs: Glucose 98.1 mg/dL, HbA1c 6.0 %, Total Cholesterol 140.3 mg/dL, HDL Cholesterol 44.8 mg/dL, Triglycerides 145.8 mg/dL, Creatinine 1.2 mg/dL
Active conditions: Prediabetes, Essential Hypertension, Type 2 Diabetes, Diabetic Neuropathy, Diabetic Retinopathy
Medications: 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet, amLODIPine 2.5 MG Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 54yo Male
Vitals: BP 106/77 mmHg, BMI 30.6, Weight 98.0 kg, HR 71 bpm
Labs: Glucose 86.4 mg/dL, Glucose (serum) 91.8 mg/dL, HbA1c 6.3 %, Total Cholesterol 183.9 mg/dL, HDL Cholesterol 53.5 mg/dL, Triglycerides 132.0 mg/dL, Creatinine 1.2 mg/dL
Active conditions: Prediabetes

Output:
## Risk Assessment

**Type 2 Diabetes: MODERATE**
- HbA1c 6.3% (prediabetes range 5.7-6.4%)
- BMI 30.6 (obese)
- Age 54 years (≥45 increases risk)
- History of prediabetes

**Hypertension: MODERATE**
- BMI 30.6 (obesity increases BP risk)

## Recommendations
1. Lifestyle counseling: diet modification, increase physical activity
2. Recheck glucose/HbA1c in 3-6 months
3. Lifestyle modifications: reduce sodium, DASH diet, exercise
4. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 9yo Male
Vitals: BP 109/80 mmHg, BMI 17.0, Weight 33.0 kg, HR 92 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 109/80 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 13yo Male
Vitals: BP 118/85 mmHg, BMI 20.4, Weight 51.1 kg, HR 73 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 118/85 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 67yo Male
Vitals: BP 110/73 mmHg, BMI 27.3, Weight 88.0 kg, HR 92 bpm
Labs: Glucose 93.2 mg/dL, Glucose (serum) 65.7 mg/dL, HbA1c 5.3 %, Total Cholesterol 162.6 mg/dL, HDL Cholesterol 55.9 mg/dL, Triglycerides 144.3 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Type 2 Diabetes, Essential Hypertension
Medications: Simvastatin 20 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 20yo Female
Vitals: BP 137/82 mmHg, BMI 23.3, Weight 68.3 kg, HR 96 bpm

Output:
## Risk Assessment

**Type 2 Diabetes: LOW**
- No significant risk factors identified

**Hypertension: MODERATE**
- BP 137/82 mmHg (elevated)

## Recommendations
1. Lifestyle modifications: reduce sodium, DASH diet, exercise
2. Recheck BP in 2-4 weeks


Instruction: Based on the following patient record, assess the risk of Type 2 diabetes and hypertension. Provide risk levels (LOW, MODERATE, HIGH, or DIAGNOSED) with supporting factors, and clinical recommendations.

Input:
Patient: 66yo Female
Vitals: BP 127/79 mmHg, BMI 29.1, Weight 77.8 kg, HR 96 bpm
Labs: Glucose 82.2 mg/dL, Glucose (serum) 82.2 mg/dL, HbA1c 2.8 %, Total Cholesterol 174.8 mg/dL, HDL Cholesterol 55.5 mg/dL, Triglycerides 102.1 mg/dL, Creatinine 0.9 mg/dL
Active conditions: Type 2 Diabetes, Essential Hypertension, Diabetic Retinopathy, Diabetic Kidney Disease
Medications: Simvastatin 20 MG Oral Tablet, insulin isophane  human 70 UNT/ML / insulin  regular  human 30 UNT/ML Injectable Suspension [Humulin], losartan potassium 25 MG Oral Tablet, Hydrochlorothiazide 25 MG Oral Tablet, 24 HR Metformin hydrochloride 500 MG Extended Release Oral Tablet

Output:
## Risk Assessment

**Type 2 Diabetes: DIAGNOSED**
- Patient has diagnosed Type 2 Diabetes

**Hypertension: DIAGNOSED**
- Patient has diagnosed Hypertension

## Recommendations
1. Assess cardiovascular risk (Framingham or ASCVD score)